Skip to main content
Premium Trial:

Request an Annual Quote

Oracle Health Sciences Institute Launched

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oracle announced earlier this week the creation of the Oracle Health Sciences Institute to accelerate IT innovation directed at personalized medicine.

The creation of the institute was done in partnership with Sun Labs, which Oracle acquired last year. Oracle will work with academic centers with a focus on research areas "fundamental to the R&D and healthcare delivery challenges facing health sciences organizations today," the company said in a statement.

Oracle's current research priorities include genomic, genetic, and phenotypic data analysis, data mining in support of clinical trials; artificial intelligence and semantic technology; predictive algorithms, and other technologies "to advance patient safety and provide advanced decision support at the point of care."

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.